Back to Research Hub
Jazz Pharmaceuticals plc
JAZZ
$232.04-6.53 (-2.74%)
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally.
StreetsValue research for Jazz Pharmaceuticals plc (JAZZ)
Members get the full report for Jazz Pharmaceuticals plc: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.